Pfizer Inc. (PFE) Balance Sheet
As of 2026-06-28 (10-Q), Pfizer Inc. (PFE) reported total assets of $201.1B, total liabilities of $115.6B and shareholders' equity of $85.2B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $976.0M. Long-term debt: $60.5B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PFEPfizer Inc.Follow PFE — free
—
Price chart with a free account
- Market cap
- 171.2B
- P/E TTM
- 39.5
- Dividend yield
- 5.7%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.98 | 1.74 | 3.18 | 10.08 | 2.18 | 3.34 | 3.64 | 2.60 | 1.34 | 1.14 | 1.12 | 1.79 | 1.94 | 0.42 | 2.85 | 1.04 | 1.14 | 0.98 | |
| Short-term investments | 23.99 | 26.28 | 23.27 | 22.32 | 30.23 | 32.78 | 19.65 | 15.26 | 18.65 | 17.69 | 8.53 | 10.44 | 22.01 | 18.74 | 4.40 | 10.88 | 9.18 | 7.28 | |
| Receivables | 14.65 | 13.38 | 13.06 | 10.68 | 9.36 | 8.40 | 8.18 | 8.23 | 8.22 | 8.03 | 6.77 | 7.91 | 11.48 | 10.95 | 11.57 | 11.46 | 11.87 | 12.49 | |
| Inventory | 12.40 | 8.28 | 6.61 | 6.08 | 6.17 | 5.66 | 7.51 | 6.78 | 7.58 | 7.51 | 7.07 | 8.02 | 9.06 | 8.98 | 10.19 | 10.85 | 10.65 | 9.95 | |
| Current assets | 61.67 | 61.01 | 60.82 | 64.83 | 56.24 | 55.60 | 43.80 | 38.95 | 41.14 | 49.93 | 32.80 | 35.07 | 59.69 | 51.26 | 43.33 | 50.36 | 42.90 | 41.36 | |
| Total assets | 212.95 | 195.01 | 188.00 | 185.80 | 172.10 | 167.57 | 167.38 | 171.62 | 171.80 | 159.42 | 167.59 | 154.23 | 181.48 | 197.21 | 226.50 | 213.40 | 208.16 | 201.13 | |
| Current liabilities | 37.23 | 28.64 | 28.91 | 29.19 | 23.37 | 21.59 | 29.40 | 31.12 | 30.43 | 31.86 | 37.30 | 25.92 | 42.67 | 42.14 | 47.79 | 43.00 | 36.98 | 32.65 | |
| Long-term debt | 43.19 | 38.41 | 34.93 | 31.04 | 30.46 | 31.54 | 28.74 | 31.40 | 33.54 | 32.91 | 35.96 | 37.13 | 36.20 | 32.88 | 61.54 | 57.41 | 61.64 | 60.50 | |
| Short-term debt | 0.03 | 3.50 | 0.01 | 2.45 | 2.06 | 3.01 | 3.72 | 4.23 | 3.55 | 4.78 | 1.46 | 2.00 | 1.64 | 2.56 | 2.25 | 3.75 | 3.00 | 2.61 | |
| Total liabilities | 122.50 | 106.75 | 105.38 | 104.12 | 95.48 | 95.94 | 102.38 | 111.78 | 100.14 | 95.66 | 104.15 | 90.76 | 104.01 | 101.29 | 137.21 | 124.90 | 121.39 | 115.64 | |
| Shareholders' equity | 90.01 | 87.81 | 82.19 | 81.26 | 76.31 | 71.30 | 64.72 | 59.54 | 71.31 | 63.41 | 63.14 | 63.24 | 77.20 | 95.66 | 89.01 | 88.20 | 86.48 | 85.19 |
USD billions · SEC XBRL
Pfizer Inc. — questions
- How much cash does Pfizer Inc. have?
- $976.0M in cash and cash equivalents as of 2026-06-28.
- How much debt does Pfizer Inc. have?
- $60.5B of long-term debt and $2.6B due within a year as of 2026-06-28.
- What are Pfizer Inc.'s total assets?
- $201.1B as of 2026-06-28.
- What is Pfizer Inc.'s shareholders' equity?
- $85.2B as of 2026-06-28.
Every figure on this page comes from Pfizer Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.